Lumiliximab
Lumiliximab Basic information
- Product Name:
- Lumiliximab
- Synonyms:
-
- Lumiliximab
- Gomiliximab
- Research Grade Lumiliximab (DHC21301)
- Research Grade Gomiliximab (DHC21302)
- Lumiliximab (anti-FceR2)
- IDEC-152|||ST-152
- Research Grade Lumiliximab
- CAS:
- 357613-86-6
- MW:
- 0
- Mol File:
- Mol File
More
Less
Lumiliximab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Lumiliximab Usage And Synthesis
Uses
Lumiliximab (Anti-CD23 Recombinant Antibody) is an anti-CD23 monoclonal antibody that inhibits allergen-induced responses[1].
References
[1] Poole JA, et al. Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects. J Allergy Clin Immunol. 2005 Oct;116(4):780-8. DOI:10.1016/j.jaci.2005.07.007
LumiliximabSupplier
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
ShangHai Biochempartner Co.,Ltd
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
TargetMol Chemicals Inc.
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
Guangzhou Hongyuan Chemical Co.,Ltd
- Tel
- 15817493340
- 981810490@qq.com
Wuhan Chemstan Biotechnology Co., Ltd.
- Tel
- 027-65317797 15926423062
- 422450190@qq.com